Jiao Wang Selected Research

Hepatocellular Carcinoma (Hepatoma)

1/2024	Statin therapy: a potential adjuvant to immunotherapies in hepatocellular carcinoma.
12/2023	LncRNA SLC1A5-AS/MZF1/ASCT2 Axis Contributes to Malignant Progression of Hepatocellular Carcinoma.
9/2022	Hypophysitis: A rare but noteworthy immune-related adverse event secondary to camrelizumab therapy.
1/2022	Long Non-Coding RNA MAFG-AS1 as a Potential Biomarker for Hepatocellular Carcinoma: Linkage with Tumor Features, Markers, Liver Functions, and Survival Profile.
1/2022	Design, synthesis, and biological evaluation of quinazoline derivatives with covalent reversible warheads as potential FGFR4 inhibitors.
12/2021	Design, synthesis and biological evaluation of quinazoline derivatives as potent and selective FGFR4 inhibitors.
11/2021	Targeting Na+ /K+ -ATPase by berbamine and ouabain synergizes with sorafenib to inhibit hepatocellular carcinoma.
4/2021	Blockade of AMPK-Mediated cAMP-PKA-CREB/ATF1 Signaling Synergizes with Aspirin to Inhibit Hepatocellular Carcinoma.
1/2020	Transarterial chemoembolization, ablation, tyrosine kinase inhibitors, and immunotherapy (TATI): A novel treatment for patients with advanced hepatocellular carcinoma.
12/2019	The regulatory protein GADD34 inhibits TRAIL-induced apoptosis via TRAF6/ERK-dependent stabilization of myeloid cell leukemia 1 in liver cancer cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiao Wang Research Topics

Disease

114	Neoplasms (Cancer) 05/2024 - 01/2008
23	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 02/2015
16	Inflammation (Inflammations) 01/2024 - 05/2011
15	Type 2 Diabetes Mellitus (MODY) 01/2024 - 01/2013
15	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 09/2014
13	Infections 01/2023 - 02/2009
13	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2008
12	Neoplasm Metastasis (Metastasis) 12/2023 - 10/2015
11	Glioblastoma (Glioblastoma Multiforme) 03/2024 - 10/2018
9	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2024 - 01/2021
9	Insulin Resistance 01/2024 - 02/2014
9	Wounds and Injuries (Trauma) 01/2024 - 01/2014
9	Carcinogenesis 01/2024 - 10/2010
9	Hypertension (High Blood Pressure) 11/2023 - 01/2013
8	Diabetic Nephropathies (Diabetic Nephropathy) 12/2024 - 05/2011
8	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 01/2020
8	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 02/2018
8	Obesity 01/2022 - 09/2013
8	Lung Neoplasms (Lung Cancer) 05/2020 - 10/2015
7	Glioma (Gliomas) 05/2024 - 10/2018
7	Fibrosis (Cirrhosis) 05/2024 - 05/2011
6	Myocardial Infarction 03/2024 - 01/2015
6	Disease Progression 08/2023 - 01/2016
6	Diabetes Mellitus 01/2023 - 06/2015
6	Pneumonia (Pneumonitis) 01/2023 - 04/2015
6	Hypoxia (Hypoxemia) 01/2022 - 08/2016
5	Liver Neoplasms (Liver Cancer) 01/2024 - 01/2018
5	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 01/2020
5	Ovarian Neoplasms (Ovarian Cancer) 08/2023 - 01/2017
5	Uveal melanoma 01/2022 - 03/2011
4	Coronary Artery Disease (Coronary Atherosclerosis) 02/2024 - 01/2015
4	Heart Failure 01/2024 - 03/2020
4	Leukemia 08/2023 - 09/2017
4	Body Weight (Weight, Body) 03/2023 - 09/2013
4	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2023 - 02/2013
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 02/2014
4	Overweight 11/2019 - 09/2013
3	Diarrhea 02/2024 - 06/2015
3	Neuroinflammatory Diseases 02/2024 - 12/2022
3	Atrial Fibrillation 01/2024 - 03/2022
3	Respiratory Insufficiency (Respiratory Failure) 01/2024 - 08/2019
3	Dyslipidemias (Dyslipidemia) 01/2024 - 09/2013
3	Pathologic Processes 01/2024 - 01/2012
3	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 12/2023 - 01/2015
3	Mitochondrial Diseases (Mitochondrial Disease) 12/2023 - 01/2021

Drug/Important Bio-Agent (IBA)

31	Proteins (Proteins, Gene)FDA Link 05/2024 - 04/2015
25	Biomarkers (Surrogate Marker)IBA 03/2024 - 10/2016
14	Long Noncoding RNAIBA 12/2023 - 01/2017
14	MicroRNAs (MicroRNA)IBA 10/2023 - 04/2009
13	Insulin (Novolin)FDA Link 01/2024 - 02/2014
11	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 05/2011
10	CytokinesIBA 01/2024 - 01/2013
10	Messenger RNA (mRNA)IBA 12/2023 - 05/2019
8	CholesterolIBA 01/2024 - 09/2013
8	Small Interfering RNA (siRNA)IBA 01/2023 - 01/2008
8	Adenosine (Adenocard)FDA LinkGeneric 01/2023 - 01/2018
7	Therapeutic UsesIBA 01/2024 - 01/2019
7	Blood Glucose (Blood Sugar)IBA 12/2023 - 09/2013
7	Transcription Factors (Transcription Factor)IBA 11/2023 - 02/2013
7	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2017
6	AntibodiesIBA 03/2024 - 01/2013
6	Circular RNAIBA 12/2023 - 01/2020
6	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2013
6	Adenosine Triphosphate (ATP)IBA 11/2022 - 11/2009
6	LipidsIBA 01/2022 - 03/2015
6	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2016
5	AntioxidantsIBA 04/2024 - 01/2016
5	EnzymesIBA 02/2024 - 12/2013
5	Hemoglobins (Hemoglobin)IBA 01/2024 - 07/2013
5	apatinibIBA 01/2024 - 01/2019
5	TeaIBA 01/2023 - 11/2009
5	CateninsIBA 01/2023 - 09/2014
5	InterleukinsIBA 01/2023 - 01/2015
5	camrelizumabIBA 09/2022 - 01/2019
5	CurcuminIBA 01/2022 - 06/2012
5	Tyrosine Kinase InhibitorsIBA 01/2020 - 06/2016
4	AntigensIBA 03/2024 - 01/2014
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2024 - 01/2015
4	Fatty Acids (Saturated Fatty Acids)IBA 01/2024 - 03/2015
4	Competitive Endogenous RNAIBA 12/2023 - 11/2020
4	Interleukin-17 (Interleukin 17)IBA 08/2023 - 01/2022
4	Uric Acid (Urate)IBA 01/2023 - 01/2013
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2014
4	Indicators and Reagents (Reagents)IBA 01/2022 - 11/2019
4	Caspase 3 (Caspase-3)IBA 01/2022 - 03/2009
4	Folic Acid (Vitamin M)FDA LinkGeneric 05/2021 - 10/2016
4	ErbB Receptors (EGF Receptor)IBA 11/2019 - 06/2016
3	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2024 - 01/2020
3	ORALIT (ORS)IBA 03/2024 - 06/2012
3	Carrier Proteins (Binding Protein)IBA 01/2024 - 01/2022
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2024 - 01/2021
3	rheinIBA 01/2024 - 03/2015

Therapy/Procedure

59	Therapeutics 03/2024 - 11/2009
17	Drug Therapy (Chemotherapy) 01/2024 - 09/2009
10	Immunotherapy 01/2024 - 01/2014
5	Chinese Traditional Medicine (Traditional Chinese Medicine) 12/2023 - 07/2004
5	Radiotherapy 08/2023 - 01/2020
5	Transplantation 12/2022 - 01/2010
4	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2023 - 11/2015
3	Glycemic Control 01/2024 - 11/2019